This message was sent to ##Email##. To advertise in this publication please click here

Oct. 16, 2020

SOCIETY NEWS

The 2020 COP Donation Derby is Here AST We just launched the 2020 COP giving contest: The Donation Derby. Watch this race, as the COPs compete for two prizes and fundraise for their upcoming initiatives. All donations made by COP members until the end of the year will count toward this contest, so be sure to check it out today. READ MORE

LAST CHANCE: AST Innovation Award AST Transplantation was founded on the spirit of innovation and experimentation. The AST created the Innovation Award to honor an individual or team whose big ideas and outside the box thinking has made a significant impact on transplantation. The award is designed to showcase successes in transplant innovation and to drive, recognize, and reward novel ideas. The deadline to apply is October 21, 2020. READ MORE

SPONSORED VIDEO Important Factors in Kidney Transplant Explore some of the many factors that can put a graft at risk, including CYP3A5*1 expression, declining adherence, and nephrotoxicity. In addition, review pharmacokinetic and clinical data that may be relevant to your practice and patients. See the Video WATCH VIDEO

Introducing the Living Donor Circle of Excellence AST The AST is proud to introduce the Living Donor Circle of Excellence program! The vision for this program was inspired by the need to increase living organ donation by removing financial barriers donors sometimes encounter. Today, many employers do not offer any kind of compensation to an employee recovering from donating an organ. The Circle aims to change that. By recognizing companies who support living donation through providing salary support post-surgery, the AST envisions more people will consider this altruistic act. READ MORE

AST Partner's Blog AST Like most non-profit organizations, the AST has many valuable relationships that contribute to its continued growth and sustainability. To give our partners the opportunity to showcase their current initiatives and news, the AST posted its October 2020 Partner's Blog. READ MORE

SPONSORED CONTENT Promoted by Natera • National Kidney Foundation CME Course: Evaluation of Acute Allograft Rejection in Kidney Transplantation • KDIGO Webinar: The Critical Role of Genetics in Kidney Disease • NEW: The Renasight Genetic Panel Can Inform the Care Path for Patients Diagnosed with CKD • Learn about Prospera for a Better Kidney Transplant Rejection Assessment • Why Prospera is the Right Choice for Managing Transplant Recipients Remotely

Improvements to the AST Specialty Information — Update Your Info Now! AST In response to your feedback, we've been making changes to support further growth in the diversity of transplant disciplines represented under the AST's umbrella. We want to ensure that everyone is represented and has a voice in the direction of the Society, and part of doing that well means knowing who you are! As a result, we've made improvements to the choices you have in your profile to describe your work and your training. We now ask about your role in transplant, and offer expanded choices (Advanced Practice Provider, Transplant Administrator, Psychologist, Social Worker, and more). Our questions about your specialty also offer additional choices, including the ability to choose Pediatrics, all solid organs, Psychosocial, or to specify Basic, Translational, or Clinical research. We hope you'll check out our new choices and update your selections. Knowing our members helps us better tailor future services for you! Login to your AST Profile and navigate to "Edit My Specialty Information" on the left to make changes anytime. As always, the AST Membership Team welcomes your feedback and suggestions at info@myast.org.

PRODUCT SHOWCASE The First and Only FDA-cleared digestive enzyme cartridge to Hydrolyze Fats in Enteral Formula RELiZORB mimics the function of pancreatic lipase and delivers absorbable fats to your patients. Indicated for use in pediatric patients (ages 5 years and above) and adult patients to hydrolyze fats in enteral formula. Learn more at relizorb.com REL20-310 LEARN MORE

Flu Shot Information for Transplant Recipients and Candidates AST The AST supports the CDC's Advisory Committee on Immunization Practices recommendations that all individuals older than 6 months of age who do not have contraindications to vaccination, including those with immunocompromising conditions (including organ transplant candidates and recipients) receive a routine annual influenza vaccination. Please be aware that this recommendation applies to the general public and is especially important for health care workers and household contacts. Check out our website to view our statement and flu shot flyer. READ MORE

COVID-19 and Transplantation: AJT Articles AST In the interest of facilitating patient care and advancing science and ensuring that accurate knowledge and experience is available to all during this current time of crisis, AJT has been expediting review of all papers dealing with COVID-19, as well as making them free to access for all. READ MORE

SPONSOR SPOTLIGHT

AST Research Network AST The AST Research Network is now accepting applications for its annual career development grants cycle! The purpose of these grants is to foster the training of early career investigators who have the potential to contribute to transplant science/immunobiology and/or treatment of transplant recipients. The grants encourage continued commitment of high-quality applicants to their careers in transplantation. Applications are accepted in basic, clinical, and translational research. READ MORE

FEATURED ARTICLE Immunosuppression in de novo kidney transplant recipients Promoted by Veloxis Pharmaceuticals There are many factors that may put a graft at risk, such as infections, nephrotoxicity, declining adherence, and inadequate immunosuppression. It can be difficult to achieve a balance between overimmunosuppression and underimmunosuppression in kidney transplant patients, putting patients at risk. READ MORE

UPCOMING EDUCATION EVENTS

Evaluating multiple living kidney donor candidates simultaneously is more cost-effective than sequentially AST Monday, November 2, 2020 | 4 pm ET REGISTER

Disparities in Access to Transplantation AST Wednesday, November 4, 2020 | 2 pm ET VIEW NOW

See more by subscribing to our YouTube channel.

TRANSPLANT NEWS

Complement Activation on Endothelium Initiates Antibody-Mediated Acute Lung Injury The Journal of Clinical Investigation Antibodies targeting human leukocyte antigen (HLA)/major histocompatibility complex (MHC) proteins limit successful transplantation and transfusion, and their presence in blood products can cause lethal transfusion-related acute lung injury (TRALI). It is unclear which cell types are bound by these anti-leukocyte antibodies to initiate an immunologic cascade resulting in lung injury. READ MORE

Impact of COVID-19 on the Care of Patients with Liver Disease: EASL-ESCMID Position Paper After 6 Months of the Pandemic JHEP During the early stages of the coronavirus disease 2019 (COVID-19) pandemic, EASL and ESCMID published a position paper to provide guidance for physicians involved in the care of patients with chronic liver disease. While some healthcare systems are returning to a more normal routine, many countries and healthcare systems have been, or still are, overwhelmed by the pandemic, which is significantly impacting on the care of these patients. I READ MORE

PRODUCT SHOWCASE

Now offering Mobile Phlebotomy Labs@HOME is a mobile phlebotomy in-home blood draw service to aid in specimen collection directly from a patient's home. Clinicians can order and customize a number of infectious disease and transplant-relatedtesting remotely LEARN MORE Reach Your Prospects Every Week Thousands of industry professionals subscribe to AST's eNews, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity. Connect with Highly Defined Buyers and Maximize Your Brand Exposure! LEARN MORE

Analysis of Survival Benefits of Living vs. Deceased Donor Liver Transplant in High MELD and Hepatorenal Syndrome AASLD Previous recommendation suggested living donor liver transplantation(LDLT) should not be considered for patients with Model for End‐stage Liver Disease(MELD)>25 and hepatorenal syndrome(HRS). READ MORE

SPONSOR SPOTLIGHT

COVID‐19 Outcomes in Patients Waitlisted for Kidney Transplantation and Kidney Transplant Recipients American Journal of Transplantation The COVID‐19 pandemic has brought unprecedented challenges to the transplant community. The reduction in transplantation volume during this time is partly due to concerns over potentially increased susceptibility and worsened outcomes of COVID‐19 in immunosuppressed recipients. The consequences of COVID‐19 on patients waitlisted for kidney transplantation, however, have not previously been characterized. READ MORE

Clinical Implications of SARS‐CoV‐2 Cycle Threshold Values in Solid Organ Transplant Recipients American Journal of Transplantation Detection of SARS‐CoV‐2 viral RNA by RT‐PCR assays is the primary diagnostic test for COVID‐19. Cycle threshold (CT) values generated by some of these assays provide inversely proportional proxy measurements of viral load. READ MORE

AST eNews   Connect with AST Dennis Hall, Director of Publishing, 469-420-2656 | Download media kit American Society of Transplantation 1120 Route 73, Suite 200 | Mount Laurel, NJ, 08054 | 856-439-9986 | Contact Us Click here to unsubscribe. Learn how to add us to your safe sender list so our emails get to your inbox. ADVERTISE SUBSCRIBE PAST ISSUES 7701 Las Colinas Ridge, Ste. 800, Irving, TX, 75063